Terms: = Ovarian cancer AND ARID1B, 6A3-5, 57492, ENSG00000049618, p250R, KIAA1235, ELD/OSA1, DAN15, BRIGHT, BAF250b AND Treatment
16 results:
1. The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma.
Miceska S; Skof E; Bucek S; Kuhar CG; Gasljevic G; Smrkolj S; Prevodnik VK
Radiol Oncol; 2023 Dec; 57(4):493-506. PubMed ID: 38038414
[TBL] [Abstract] [Full Text] [Related]
2. Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA-1 multinomial regression model: validation study.
Heremans R; Wynants L; Valentin L; Leone FPG; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Van den Bosch T;
Ultrasound Obstet Gynecol; 2024 Apr; 63(4):556-563. PubMed ID: 37927006
[TBL] [Abstract] [Full Text] [Related]
3. Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer.
Kumar P; Ranmale S; Mehta S; Tongaonkar H; Patel V; Singh AK; Mania-Pramanik J
J Ovarian Res; 2023 Jun; 16(1):114. PubMed ID: 37322531
[TBL] [Abstract] [Full Text] [Related]
4. Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study.
Cao G; Hua D; Li J; Zhang X; Zhang Z; Zhang B; Bei T; Cui L; Chen S; Wang S; Zhu L
Front Immunol; 2023; 14():1022942. PubMed ID: 36993949
[TBL] [Abstract] [Full Text] [Related]
5. The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future.
Foster JM; Zhang C; Rehman S; Sharma P; Alexander HR
CA Cancer J Clin; 2023 Jan; 73(1):49-71. PubMed ID: 35969103
[TBL] [Abstract] [Full Text] [Related]
6. Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3).
Heremans R; Van Den Bosch T; Valentin L; Wynants L; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Leone FPG;
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):243-255. PubMed ID: 35385178
[TBL] [Abstract] [Full Text] [Related]
7. Optimization of Follicle Isolation for Bioengineering of Human Artificial Ovary.
Chen J; Isachenko E; Wang W; Du X; Wang M; Rahimi G; Mallmann P; Isachenko V
Biopreserv Biobank; 2022 Dec; 20(6):529-539. PubMed ID: 34936496
[No Abstract] [Full Text] [Related]
8. [The composition of ascites lymphocytes in high-grade serous ovarian cancer and its correlation with clinical features].
He TH; Zhang J; Yin ZN; Zhang X; Li Y; Wu Y; Li HJ; Liang HM; Xue LX; Guo HY
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2375-2381. PubMed ID: 34404130
[No Abstract] [Full Text] [Related]
9. Targeted MRI and chemotherapy of ovarian cancer with clinic available nano-drug based nanoprobe.
Dong L; Zhang X; Cai L; Zuo F; Zhao M; Wang Q; Zhang S; Xu K; Li J
Biomed Pharmacother; 2020 Oct; 130():110585. PubMed ID: 32771892
[TBL] [Abstract] [Full Text] [Related]
10. Anticancer effects of Rosmarinic acid in OVCAR-3 ovarian cancer cells are mediated via induction of apoptosis, suppression of cell migration and modulation of lncRNA MALAT-1 expression.
Zhang Y; Hu M; Liu L; Cheng XL; Cai J; Zhou J; Wang T
J BUON; 2018; 23(3):763-768. PubMed ID: 30003749
[TBL] [Abstract] [Full Text] [Related]
11. ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors.
Berns K; Caumanns JJ; Hijmans EM; Gennissen AMC; Severson TM; Evers B; Wisman GBA; Jan Meersma G; Lieftink C; Beijersbergen RL; Itamochi H; van der Zee AGJ; de Jong S; Bernards R
Oncogene; 2018 Aug; 37(33):4611-4625. PubMed ID: 29760405
[TBL] [Abstract] [Full Text] [Related]
12. Procyanidin-rich extract of natural cocoa powder causes ROS-mediated caspase-3 dependent apoptosis and reduction of pro-MMP-2 in epithelial ovarian carcinoma cell lines.
Taparia SS; Khanna A
Biomed Pharmacother; 2016 Oct; 83():130-140. PubMed ID: 27470560
[TBL] [Abstract] [Full Text] [Related]
13. The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications.
Rida PC; LiVecche D; Ogden A; Zhou J; Aneja R
Med Res Rev; 2015 Sep; 35(5):1072-96. PubMed ID: 26179481
[TBL] [Abstract] [Full Text] [Related]
14. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.
Provenza C; Young RH; Prat J
Am J Surg Pathol; 2008 Mar; 32(3):383-9. PubMed ID: 18300813
[TBL] [Abstract] [Full Text] [Related]
15. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.
Davies B; Brown PD; East N; Crimmin MJ; Balkwill FR
Cancer Res; 1993 May; 53(9):2087-91. PubMed ID: 8347186
[TBL] [Abstract] [Full Text] [Related]
16. [Tumor of the ovarian juvenile granulose cells. Presentation of a case with an immunohistochemical and ultrastructural study].
Velasco Sánchez MG; Jiménez Cordero AA; Astengo Osuna C
Ginecol Obstet Mex; 1991 Jan; 59(1):28-31. PubMed ID: 2066013
[TBL] [Abstract] [Full Text] [Related]